AMEX:SSY

Stock Analysis Report

SunLink Health Systems

Executive Summary

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare services in the southeastern United States.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.


Similar Companies

Share Price & News

How has SunLink Health Systems's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.6%

SSY

-0.08%

US Healthcare

1.3%

US Market


1 Year Return

-14.8%

SSY

-10.6%

US Healthcare

5.9%

US Market

Return vs Industry: SSY underperformed the US Healthcare industry which returned -10.6% over the past year.

Return vs Market: SSY underperformed the US Market which returned 5.9% over the past year.


Shareholder returns

SSYIndustryMarket
7 Day3.6%-0.08%1.3%
30 Day-13.5%-4.1%-1.9%
90 Day-24.8%-9.4%-1.8%
1 Year-14.8%-14.8%-9.2%-10.6%8.3%5.9%
3 Year-9.4%-9.4%28.9%23.7%45.6%36.2%
5 Year-12.9%-12.9%58.9%49.4%66.1%47.9%

Price Volatility Vs. Market

How volatile is SunLink Health Systems's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is SunLink Health Systems undervalued compared to its fair value and its price relative to the market?

0.53x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate SSY's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate SSY's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SSY is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: SSY is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate SSY's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SSY is good value based on its PB Ratio (0.5x) compared to the US Healthcare industry average (2.4x).


Next Steps

Future Growth

How is SunLink Health Systems forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SunLink Health Systems has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has SunLink Health Systems performed over the past 5 years?

-1.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: SSY is unprofitable, and losses have increased over the past 5 years at a rate of -1.7% per year.

Accelerating Growth: Unable to compare SSY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SSY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (5.3%).


Return on Equity

High ROE: SSY has a negative Return on Equity (-13.27%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: SSY is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: SSY is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is SunLink Health Systems's financial position?


Financial Position Analysis

Short Term Liabilities: SSY's short term assets ($16.7M) exceeds its short term liabilities ($8.4M)

Long Term Liabilities: SSY's short term assets (16.7M) exceeds its long term liabilities (966.0K)


Debt to Equity History and Analysis

Debt Level: SSY's debt to equity ratio (19.7%) is considered satisfactory

Reducing Debt: SSY's debt to equity ratio has reduced from 37.7% to 19.7% over the past 5 years.


Balance Sheet

Inventory Level: SSY has a high level of physical assets or inventory.

Debt Coverage by Assets: SSY's debt is covered by short term assets (assets are 5.622000x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SSY has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SSY has sufficient cash runway for 1.504593 years if free cash flow continues to grow at historical rates of 34.4% each year.


Next Steps

Dividend

What is SunLink Health Systems's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.7%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate SSY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate SSY's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if SSY's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SSY's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SSY's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of SunLink Health Systems's salary, the management and board of directors tenure and is there insider trading?

9.0yrs

Average management tenure


CEO

Robert Thornton (70yo)

21.1yrs

Tenure

US$440,311

Compensation

Mr. Robert M. Thornton, Jr. has been an Executive Chairman and Chief Executive Officer of Sunlink Health Systems Inc. since September 10, 1998 and has been its President since July 16, 1996. Since October  ...


CEO Compensation Analysis

Compensation vs. Market: Robert's total compensation ($USD440.31K) is about average for companies of similar size in the US market ($USD495.77K).

Compensation vs Earnings: Robert's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

9.0yrs

Average Tenure

69.5yo

Average Age

Experienced Management: SSY's management team is seasoned and experienced (9 years average tenure).


Board Age and Tenure

20.3yrs

Average Tenure

77yo

Average Age

Experienced Board: SSY's board of directors are seasoned and experienced ( 20.3 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellUS$91,65929 Mar 19
Steven Baileys
EntityIndividual
Role
Member of the Board of Directors
Director
Shares59,695
Max PriceUS$1.55
SellUS$827 Mar 19
Steven Baileys
EntityIndividual
Role
Member of the Board of Directors
Director
Shares5
Max PriceUS$1.55
SellUS$46527 Mar 19
Steven Baileys
EntityIndividual
Role
Member of the Board of Directors
Director
Shares300
Max PriceUS$1.55

Ownership Breakdown


Management Team

  • Robert Thornton (70yo)

    Executive Chairman

    • Tenure: 21.1yrs
    • Compensation: US$440.31k
  • James Mulligan (97yo)

    General Counsel & Director Emeritus

    • Tenure: 0yrs
  • Mark Stockslager (60yo)

    CFO & Principal Accounting Officer

    • Tenure: 12.3yrs
    • Compensation: US$220.55k
  • Byron Finn (69yo)

    President of SunLink ScriptsRX

    • Tenure: 9yrs
    • Compensation: US$248.17k
  • Theresa Mota

    Secretary

    • Tenure: 0yrs
  • Stephanie Woods

    Chief Executive Officer of SunLink Health Systems Technology

    • Tenure: 0.8yrs
  • Sheila Brockman

    Chief Executive Officer of Southern Health Corporation of Ellijay

    • Tenure: 0.8yrs

Board Members

  • Robert Thornton (70yo)

    Executive Chairman

    • Tenure: 21.1yrs
    • Compensation: US$440.31k
  • James Mulligan (97yo)

    General Counsel & Director Emeritus

    • Tenure: 0yrs
  • Steven Baileys (65yo)

    Director

    • Tenure: 19.8yrs
    • Compensation: US$39.50k
  • C. Ford (80yo)

    Director

    • Tenure: 20.8yrs
    • Compensation: US$43.00k
  • Howard Turner (77yo)

    Director

    • Tenure: 20.8yrs
    • Compensation: US$39.50k
  • Gene Burleson (78yo)

    Director

    • Tenure: 16.8yrs
    • Compensation: US$43.00k
  • Chris Mills (65yo)

    Director

    • Tenure: 12.3yrs
    • Compensation: US$39.50k

Company Information

SunLink Health Systems, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SunLink Health Systems, Inc.
  • Ticker: SSY
  • Exchange: AMEX
  • Founded: 1959
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$8.035m
  • Shares outstanding: 6.99m
  • Website: https://www.sunlinkhealth.com

Location

  • SunLink Health Systems, Inc.
  • 900 Circle 75 Parkway
  • Suite 1120
  • Atlanta
  • Georgia
  • 30339
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SSYAMEX (NYSE MKT LLC)YesCommon SharesUSUSDJul 1986

Biography

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Se ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 23:43
End of Day Share Price2019/10/11 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.